NasdaqGM - Nasdaq Real Time Price USD
Cartesian Therapeutics, Inc. (RNAC)
11.03
+1.69
+(18.15%)
At close: June 6 at 4:00:00 PM EDT
11.25
+0.22
+(1.95%)
Pre-Market: 7:15:02 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 771.43k | 771.43k | 3.48M | 337.5k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 5M | 5M | 20M | 1.6M |
| Year Ago Sales | 33.45M | 387k | 38.91M | 3.48M |
| Sales Growth (year/est) | -97.69% | 99.34% | -91.07% | -90.29% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.55 | -0.83 | -0.71 |
| EPS Actual | 0.64 | -0.42 | -0.59 | -0.65 |
| Difference | 0.73 | 0.13 | 0.23 | 0.06 |
| Surprise % | 770.53% | 23.09% | 28.13% | 7.89% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RNAC | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
| Maintains | Needham: Buy to Buy | 5/8/2025 |
| Reiterates | Needham: Buy to Buy | 4/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/9/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/14/2025 |
| Reiterates | Needham: Buy to Buy | 3/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/28/2025 |
Related Tickers
CGEM Cullinan Therapeutics, Inc.
9.08
+3.89%
BCYC Bicycle Therapeutics plc
8.55
+0.59%
TCRX TScan Therapeutics, Inc.
1.8000
+7.14%
KYTX Kyverna Therapeutics, Inc.
3.3900
+15.31%
OVID Ovid Therapeutics Inc.
0.3186
+1.69%
DSGN Design Therapeutics, Inc.
4.0100
+0.25%
NERV Minerva Neurosciences, Inc.
1.8400
+2.79%
XNCR Xencor, Inc.
9.65
+5.81%
IDYA IDEAYA Biosciences, Inc.
21.73
+2.99%
JANX Janux Therapeutics, Inc.
26.21
+5.86%